Charles J. Lacey
York, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Knowledge and acceptability of male HPV vaccination among young people and community stakeholders in northwest Tanzania: social sciences in the Add-Vacc trial.
Journal: Vaccine
Published: September 22, 2025
Immunogenicity of one and two doses of Gardasil®9 in Tanzanian girls in the DoRIS Trial.
Journal: NPJ vaccines
Published: July 15, 2025
Memory B-cells elicited by different HPV vaccine regimens in the DoRIS randomised controlled trial.
Journal: NPJ vaccines
Published: June 16, 2025
Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.
Journal: The Lancet. Global health
Published: April 21, 2024
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials.
Journal: The Lancet. Global health
Published: August 09, 2023
Unresolved issues in the management of human papillomavirus-associated mucosal high-grade pre-cancers.
Journal: Tumour virus research
Published: September 07, 2022
LEISH2b - A phase 2b study to assess the safety, efficacy, and immunogenicity of the Leishmania vaccine ChAd63-KH in post-kala azar dermal leishmaniasis.
Journal: Wellcome open research
Published: July 26, 2022
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial.
Journal: The Lancet. Global health
Published: February 20, 2022
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.
Journal: The Lancet. Global health
Published: February 20, 2022
Vaccines against leishmaniasis: using controlled human infection models to accelerate development.
Journal: Expert review of vaccines
Published: October 19, 2021
Does the number of doses matter? A qualitative study of HPV vaccination acceptability nested in a dose reduction trial in Tanzania.
Journal: Tumour virus research
Published: December 28, 2020
Last Updated: 09/26/2026